Richard J. McMullen Jr.

Dr. Richard J. McMullen Jr.

Department of Clinical Sciences, Auburn University College of Veterinary Medicine, 1130 Wire Road, Auburn, AL 36849, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Veterinary Clinics of North America: Equine Practice
Verified
Journal Article
Closed access
RJRichard J. McMullen Jr.
Richard J. McMullen Jr.
BFBritta Maria Fischer
Britta Maria Fischer

16 January 2019 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
BFBritta M. Fischer
Britta M. Fischer
RJRichard J. McMullen Jr.
Richard J. McMullen Jr.
SRSven Reese
Sven Reese
WBWalter Brehm
Walter Brehm
Despite appropriate medical therapy, many horses with equine recurrent uveitis continue to suffer from recurrent bouts of inflammation. Surgical intervention via the pars plana vitrectomy or suprachoroidal cyclosporine implant placement may control and/or prevent recurrences, however, these procedures may be contraindicated, unavailable, or declined by an owner. Thus, an effective adjunctive treatment option may help to improve the clinical outcomes in those situations. There are several anecdotal reports on the use of intravitreal gentamicin injections, but to date, no data evaluating the complication rate and/or treatment effect following this treatment have been published. Thus, the aim of this prospective study was to describe the intravitreal gentamicin injection technique, describe the associated peri-injection (within 24 h) and post-injection (30 to 780 days) complications, and to report the effects of the injection on the clinical signs of uveitis. Additionally, evaluation of the systemic and ocular Leptospira-status, and its effect on the treatment outcome was performed. A total of 86 horses of various ages, breeds, and gender presenting with recurrent or persistent uveitis were treated via intravitreal injection of 4 mg of undiluted gentamicin (0.04 ml, Genta 100, 100 mg/ml in 35 horses) or preservative-free gentamicin (0.05 ml, 80 mg/ml in 52 horses) under sedation and local anesthesia. All 86 horses were observed for immediate peri-injection and post-injection complications. Response to therapy was evaluated in 59 of the 86 horses (follow-up: 30 to 780 days). Peri-injection complications consisted of subconjunctival (26/86; 30.2%) or intracameral hemorrhage (4/86; 4.7%); both of which completely resolved within 5 days. Post-injection complications consisted of cataract formation/maturation (5/59 horses, 8.5%) and diffuse retinal degeneration (3/59 eyes 5.1%). The majority of horses 52/59 (88.1%) with a minimum follow-up period of 30 days were controlled (absence of recurrent or persistent inflammation) at their last recheck examination. Recurrent inflammation was documented in 5/59 (8.5%) horses and persistent inflammation was diagnosed in 2/59 (3.4%) horses. Intravitreal injection of low-dose gentamicin shows promise at controlling different types and stages of uveitis. The ability of intravitreal injections of low-dose gentamicin (4 mg) to control persistent and recurrent inflammation warrants further investigation.


2 July 2021 in Veterinary Ophthalmology
Verified
Journal Article
Closed access
PDF file
LCLauren N. Charnock
Lauren N. Charnock
DKDeborah A. Keys
Deborah A. Keys
RJRichard J. McMullen Jr.
Richard J. McMullen Jr.

1 December 2024 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Open access
PDF file
RJRichard J. McMullen Jr.
Richard J. McMullen Jr.
OBJECTIVE: To review data on the advances in equine ophthalmic imaging that have been made during the past 5 years and highlight advantages of using multiple imaging modalities to improve clinical observational skills and improve diagnostic accuracy. METHODS: A literature review from 2019 through 2024 of equine ophthalmic digital photography, fundus photography, ocular and orbital ultrasonography (US), ultrasound biomicroscopy (UBM), confocal microscopy (CM), spectral domain optical coherence tomography (SD-OCT), radiography, CT, and MRI. RESULTS: Digital photography remains the cornerstone of equine ophthalmic imaging for documenting examination findings, sharing information with colleagues, and consulting with specialists. Digital images also allow for in-depth postexamination review and evaluation, often revealing subtleties that may have otherwise gone undetected during the ophthalmic examination. Advanced imaging modalities are being used more frequently in equine ophthalmology, especially those that can be used with the horses standing under sedation, including US, UBM, SD-OCT, CM, and CT. DISCUSSION: Advances in equine ophthalmic imaging have led to many new clinical discoveries and to an increase in our knowledge of ocular anatomy and diseases in the horse. Many of these advanced diagnostic imaging modalities, such as MRI, CT, SD-OCT, and CM, are cost prohibitive and require substantial operator training to ensure proficiency. However, their availability in tertiary referral centers, such as veterinary teaching hospitals and large equine clinics/practices, is becoming more widespread. CONCLUSIONS: Advanced equine ophthalmic imaging data contributes substantially to our general understanding of clinical and applied anatomy and improves our understanding of the underlying pathogenesis associated with specific diseases.

29 September 2021 in Veterinary Ophthalmology
Verified
Journal Article
Closed access
PDF file
AKAlessandra V. Keenan
Alessandra V. Keenan
SOSeth Oster
Seth Oster
RJRichard J. McMullen Jr.
Richard J. McMullen Jr.
GSGillian C. Shaw
Gillian C. Shaw
RDRichard R. Dubielzig
Richard R. Dubielzig
SBShannon D. Boveland
Shannon D. Boveland